Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.49 |
| ▸ | FABP7 | O15540 | 1/20 | 0.48 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | CASP6 | P55212 | 1/20 | 0.46 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20054225 | 0.82 | HPGD (0.48) | ELANEFABP7FABP5ALDH1A1HPGD | |
| SCHEMBL19749101 | 0.81 | ALDH1A1 (0.52) | FABP7FABP5ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL16648788 | 0.81 | ALDH1A1 (0.52) | FABP7FABP5ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL29433900 | 0.81 | ALDH1A1 (0.52) | FABP7FABP5ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL8761305 | 0.81 | ALDH1A1 (0.45) | ELANEALDH1A1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL20253575 | 0.81 | FABP7 (0.46) | ELANEFABP7FABP5ALDH1A1HPGD | |
| SCHEMBL6024964 | 0.81 | ELANE (0.45) | ELANEFABP7FABP5ALDH1A1HPGD | |
| SCHEMBL6024185 | 0.81 | ELANE (0.45) | ELANEFABP7FABP5ALDH1A1HPGD | |
| SCHEMBL26679383 | 0.81 | GAA (0.50) | ELANEFABP7FABP5ALDH1A1HPGD | |
| SCHEMBL2023884 | 0.81 | ELANE (0.45) | ELANEFABP7FABP5ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117089060-A | Initiation/catalyst, preparation method and application thereof, polylactic acid-polymalic acid, preparation method and application thereof | 西北工业大学 | 2023-11-21 | — | — | CN | disclosed |
| WO-2013019658-A2 | SYNTHETIC NANOCARRIERS COMPRISING POLYMERS COMPRISING MULTIPLE IMMUNOMODULATORY AGENTS | SELECTA BIOSCIENCES, INC. (US) | 2013-02-07 | — | — | WO | disclosed |
| US-8267990-B2 | Controlled degradation of stents | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2012-09-18 | — | — | US | disclosed |
| US-20110098803-A1 | Controlled Degradation Of Stents | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2011-04-28 | — | — | US | disclosed |
| US-7794495-B2 | Controlled degradation of stents | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2010-09-14 | — | — | US | disclosed |
| US-7557176-B2 | Polyhydroxyalkanoic acid having vinyl, ester, carboxyl or sulfonic acid group and producing method therefor | CANON KABUSHIKI KAISHA (JP) | 2009-07-07 | — | — | US | disclosed |
| US-7557176-B2 | Polyhydroxyalkanoic acid having vinyl, ester, carboxyl or sulfonic acid group and producing method therefor | CANON KABUSHIKI KAISHA (JP) | 2009-07-07 | — | — | US | disclosed |
| EP-1758948-B1 | POLYHYDROXYALKANOIC ACID HAVING VINYL, ESTER, CARBOXYL OR SULFONIC ACID GROUP AND PRODUCING METHOD THEREFOR | CANON KK (JP) | 2009-05-13 | — | — | EP | disclosed |
| US-20080064828-A1 | Polyhydroxyalkanoic Acid Having Vinyl, Ester, Carboxyl or Sulfonic Acid Group and Producing Method Therefor | CANON KABUSHIKI KAISHA (JP) | 2008-03-13 | — | — | US | disclosed |
| US-20080064828-A1 | Polyhydroxyalkanoic Acid Having Vinyl, Ester, Carboxyl or Sulfonic Acid Group and Producing Method Therefor | CANON KABUSHIKI KAISHA (JP) | 2008-03-13 | — | — | US | disclosed |
| US-20080015686-A1 | Controlled degradation of stents | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2008-01-17 | — | — | US | disclosed |
| WO-2007005253-A1 | BIODEGRADABLE POLYMER FOR COATING | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2007-01-11 | — | — | WO | disclosed |
| US-20070005130-A1 | Biodegradable polymer for coating | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-01-04 | — | — | US | disclosed |
| US-20070005130-A1 | Biodegradable polymer for coating | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-01-04 | — | — | US | disclosed |
| US-5977330-A | AS HUMECTANTS FOR SKIN AND MUCOUS MEMBRANES; ANTIDEPOSIT AGENTS | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-11-02 | — | — | US | disclosed |
| US-5708152-A | DERIVATIVES AS HUMECTANTS AND ANTIDEPOSIT AGENTS | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064828-A1 | Polyhydroxyalkanoic Acid Having Vinyl, Ester, Carboxyl or Sulfonic Acid Group and Producing Method Therefor | FAR1, ACSL4, ACAD11 | ELANE 3588/4885FABP7 656/4885FABP5 617/4885 |
| US-20070005130-A1 | Biodegradable polymer for coating | MAL2, MGAM, CD44 | ELANE 933/4885FABP7 1642/4885FABP5 2147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.